MEDISTEP (MEDISTEP) fundamentals
MEDISTEP is a listed company, part of the Trading sector, listed on the NSE as MEDISTEP (ISIN INE0UOY01019). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What MEDISTEP does
Medistep healthcare Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing sanitary pads, energy powder and trading a diverse range of pharmaceutical products. It is also engaged in trading and distribution of pharmaceutical, nutraceutical, surgical and intimate Care Products. Its manufacturing products include Intimate Care and Hygeine Products (Drystep Sanitary Pad) and Nutraceuticals Products (Vitastep-Z Energy Powder). It is also focused he business of manufacturing and distribution, wholesale and retail trade of all kinds of pharmaceuticals including controlled drugs, active pharmaceutical ingredient (API), antibiotics, drugs, medicine, biologicals, nutraceuticals, organic, food items, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, among others.
Valuation and market data
| Last close | ₹23.40 |
|---|---|
| Market capitalisation | ₹30 crore |
| Enterprise value | ₹29 crore |
| P/E (TTM) | 0.82 |
| Price to book | 0.79 |
| Price to sales (TTM) | 0.18 |
| Book value per share | ₹29.60 |
| Dividend yield | 0.00% |
| Sector | Trading |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹71 crore | ₹8 crore | ₹6 crore | 4.68 |
| Mar 2025 | ₹50 crore | ₹6 crore | ₹4 crore | 4.01 |
| Mar 2024 | ₹32 crore | ₹4 crore | ₹3 crore | 19.96 |
| Mar 2023 | ₹7 crore | ₹1 crore | ₹0 crore | 0.00 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 69.0% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 31.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.